Ophelia Brown

Genesis Innovation Group LLC (Genesis Innovation Group) is a venture capital firm founded in 2013 by Rob Ball and Don Running. The firm is headquartered in Grand Rapids, Michigan.

Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California.

CenterPoint Ventures Co. LLC (CenterPoint Ventures) is a venture capital firm founded in 1996 by Robert J. Paluck and Kent A. Fuka. The firm is headquartered in Austin, Texas.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

GI Manager LP (GI Manager) is a private equity firm founded by Richard Allen Magnuson and Michael F. Foust in 2001. The firm is headquartered in San Francisco, California.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Catamount Ventures Management LLC (Catamount Ventures) is a venture capital firm founded in 2000 by Jed Smith. The firm is headquartered in San Francisco, California.

SDG Corp. provides information security and risk services. Its services include identify and access governance, secure cloud, secure mobile, risk assurance and digital collaboration and solutions include information technology risk, information technology compliance, information technology operations and business integration. The company was founded by Ajay Gupta in 1993 and is headquartered in Norwalk, CT.

Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.

iCON Infrastructure LLP is a private equity firm founded in 2004 by Paul Malan. The firm is headquartered in London, United Kingdom with offices in Germany, Canada and the United States.

Founded in 2011, Index Venture Management (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Index Venture Management SA

Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands.

Mansford LLP provides investment advice. It operates as a private european multi-strategy real estate investment firm. The company was founded by Oliver Smith in 1995 and is headquartered in London, the United Kingdom.

Felix Capital Partners LLP is a Venture Capital firm founded in 2014 by Frédéric Court. Felix Capital Partners LLP is headquartered in London.

Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.

Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom.

Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA.

Impact Biomedicines, Inc. engages in the development of cancer treatments. It engages in the development of fedratinib, a potent and selective oral molecule JAK2 kinase inhibitor for the treatment of myelofibrosis and polycythemia vera. The company was founded by John Hood, Catriona Jamieson and Raghu Saripalli in 2016 and is headquartered in San Diego, CA.

UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom.

Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA.

Fat Llama Ltd. operates an online platform that helps householders to rent domestic goods in their surroundings. The firm provides cheaper solution than buying outright or hiring from rental shops. The company was founded by Chaz Englander, Rosie Dallas and Owen Turner-Major and is headquartered in London, the United Kingdom.

Original Capital LLC (Original Capital) is a venture capital firm founded in 2016. The firm is headquartered in San Francisco, California.

Duffel Technology Ltd. provides travel solutions. The company was founded by Steve David Domin, Vincent Pastor, and Thomas Edward Christopher Bates on February 5, 2018 and is headquartered in Sheffield, the United Kingdom.

Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany.

Quilvest Capital Partners Management LLC is a Private Equity/Venture Capital firm, a subsidiary of Quilvest & Partners SA founded in 2012. Quilvest Capital Partners Management LLC is headquartered in New York.

Tines Security Services Ltd. engages in development of an security automation platform. It features direct integration, simple deployment, and secure and private. The company was founded by Eoin Hinchy in 2018 and is headquartered in Dublin, Ireland.

Moonfire Ventures LLP (Moonfire Ventures) is a venture capital firm founded in 2019 by Mattias Lennart Seve Ljungman. The firm is headquartered in London.

Vaderis Therapeutics AG is a clinical stage biotech company based in Basel, Switzerland. The Swiss company aims to develop medicinal treatments for rare and orphan diseases associated with vascular malformations. The company focuses on developing a medicine for the treatment of HHT and other diseases associated with vascular malformations. HHT is a rare disease that causes vascular overgrowth due to genetic mutations, and there are no drugs approved anywhere in the world that specifically treat it. The company was founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard, and Nicholas Benedict has been the CEO since incorporation. Vaderis raised a series a financing from Medicxi and acquired a portfolio of allosteric Akt inhibitors from Almac Discovery Ltd.